Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 33% ± 5% | |
glutamatergic neuron | 3 studies | 41% ± 6% | |
oligodendrocyte | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 29% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1495.93 | 1445 / 1445 | 100% | 17.25 | 183 / 183 |
lung | 100% | 1657.10 | 578 / 578 | 100% | 15.32 | 1155 / 1155 |
brain | 100% | 1229.80 | 2636 / 2642 | 100% | 12.51 | 705 / 705 |
breast | 100% | 1671.54 | 459 / 459 | 100% | 16.59 | 1114 / 1118 |
stomach | 100% | 1383.70 | 359 / 359 | 99% | 14.72 | 284 / 286 |
prostate | 100% | 1366.86 | 245 / 245 | 99% | 12.23 | 498 / 502 |
thymus | 100% | 1593.05 | 653 / 653 | 99% | 10.93 | 599 / 605 |
bladder | 100% | 1562.24 | 21 / 21 | 99% | 11.99 | 499 / 504 |
intestine | 100% | 1662.80 | 966 / 966 | 99% | 14.09 | 521 / 527 |
uterus | 100% | 1560.48 | 170 / 170 | 99% | 12.69 | 453 / 459 |
pancreas | 100% | 907.98 | 327 / 328 | 98% | 11.82 | 175 / 178 |
kidney | 100% | 1445.72 | 89 / 89 | 98% | 12.17 | 881 / 901 |
liver | 100% | 1178.99 | 226 / 226 | 97% | 8.85 | 395 / 406 |
adrenal gland | 100% | 1658.92 | 258 / 258 | 97% | 14.36 | 222 / 230 |
ovary | 100% | 1284.42 | 180 / 180 | 97% | 8.41 | 415 / 430 |
skin | 100% | 1513.06 | 1809 / 1809 | 93% | 11.31 | 438 / 472 |
adipose | 100% | 1794.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1673.27 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1618.08 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1464.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.01 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.37 | 1 / 1 |
heart | 97% | 888.11 | 834 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 12.16 | 28 / 29 |
peripheral blood | 93% | 1349.25 | 866 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 6.48 | 63 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0043200 | Biological process | response to amino acid |
GO_0006954 | Biological process | inflammatory response |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0010034 | Biological process | response to acetate |
GO_0003009 | Biological process | skeletal muscle contraction |
GO_0061847 | Biological process | response to cholecystokinin |
GO_0045087 | Biological process | innate immune response |
GO_0007249 | Biological process | canonical NF-kappaB signal transduction |
GO_0009615 | Biological process | response to virus |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0033194 | Biological process | response to hydroperoxide |
GO_0051146 | Biological process | striated muscle cell differentiation |
GO_0032727 | Biological process | positive regulation of interferon-alpha production |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0006955 | Biological process | immune response |
GO_0098586 | Biological process | cellular response to virus |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0007252 | Biological process | I-kappaB phosphorylation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0007266 | Biological process | Rho protein signal transduction |
GO_0038061 | Biological process | non-canonical NF-kappaB signal transduction |
GO_0006468 | Biological process | protein phosphorylation |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0009636 | Biological process | response to toxic substance |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0035631 | Cellular component | CD40 receptor complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0008385 | Cellular component | IkappaB kinase complex |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008384 | Molecular function | IkappaB kinase activity |
GO_1990459 | Molecular function | transferrin receptor binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CHUK |
Protein name | Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK-1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16) Inhibitor of nuclear factor kappa-B kinase subunit alpha (EC 2.7.11.10) (Nuclear factor NF-kappa-B inhibitor kinase alpha) |
Synonyms | TCF16 IKKA |
Description | FUNCTION: Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses . Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues . These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome . In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis . Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11) . Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes . In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Participates also in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities . Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP . Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor . Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates AMBRA1 following mitophagy induction, promoting AMBRA1 interaction with ATG8 family proteins and its mitophagic activity . . |
Accessions | Q562E6 O15111 ENST00000370397.8 |